A new report by IMS Institute for Healthcare Information announces U.S drug spending during 2014 at a record $374 billion. The record spend represented a 13% increase over 2013.  This should come as no surprise to prescription drug plan sponsors trying to control and reduce prescription drug costs.  They’ve watched as the predictions regarding specialty […]

The PBM world is shaken up again with United Healthcare’s announcement that it will acquire Catamaran and combine it with their current PBM operation, OptumRx. The deal was announced with United paying a 27% premium for the right to solidify it’s number three position in  the lineup of the latest arrangement of “The Big Three” […]

Twenty years of discussions, bad publicity, lawsuits, settlements and presentations, and choosing a PBM has still retained it’s air of confusion, double-speak and bewilderment! Prescription drug are an integral component in managing overall healthcare costs, and the attempt by plan sponsors and payers to make sense of it all can be a fatiguing exercise. That’s […]